ClinicalTrials.govpublic full text
MEDI4736 and Tremelimumab in Treating Patients With Metastatic HER2 Negative Breast Cancer
estrogen receptor negative, estrogen receptor positive, her2/neu negative, recurrent breast carcinoma, stage iv breast cancer, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 873066
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.